Perk Labs Inc.

The company's financials show resilient growth, with revenue advancing from $11181.00 in Q4 2022 to $9935.00 in Q3 2023. Gross profit remained healthy with margins at 10% in Q3 2023 compared to 20% in Q4 2022. Operating income hit -$593263.00 last quarter, sustaining a consistent -5971% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$592084.00. Net income rose to -$591620.00, while earnings per share reached -$0.001. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.